Koustav Sarkar
Koustav Sarkar is an expert in Immunology at SRM Institute of Science and Technology (India). As of October 2026, ScienceLeadR ranks Koustav Sarkar in the top 1% of experts in India for Lung Neoplasms and Thoracic Neoplasms. Koustav Sarkar has authored 98 publications, the most recent in 2026. SLR score: 423 (community average: 125). How the SLR is computed.
LeadR Profile
Immunology
Subspecialties: Oncology - Genetics - Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2006 - 2026
Number : 98
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Association of Xeroderma Pigmentosum group F (XPF) with epigenetic regulation of T helper cell differentiation in coronary artery disease-associated prostate cancer. PMID 42870424 — cells, cell differentiation, coronary artery disease, neoplasms, prostate, arteries, dna methylation, prostatic neoplasms, immunity, xeroderma pigmentosum, t-lymphocytes, helper-inducer | Epigenomics | 2026 | 0 |
| Empowering cancer therapy: the promise of natural adjuvants. PMID 42801348 — cells, major histocompatibility complex, neoplasms, liver, therapeutics | Mol Biol Rep | 2026 | 0 |
| Neem leaf glycoprotein mediated immunomodulation and epigenetic regulation in Acute Myeloid Leukemia. PMID 42690245 — cells, genes, immunomodulation, lymphocytes, molecular biology, neoplasms, leukemia, leukemia, myeloid, acute, leukemia, myeloid, glycoproteins, immunity | Mol Biol Rep | 2026 | 0 |
| Advanced gene editing technologies for oncology mechanisms, applications, and clinical implementation. PMID 42624898 — genes, neoplasms, genome, liver, gene editing, transcription activator-like effector nucleases, therapeutics | Cancer Gene Ther | 2026 | 0 |
| Association of wheatgrass (Triticum aestivum) preparation in regulation of antigen presentation through the immunomodulation and epigenetic modification in acute leukemia. PMID 42404977 — cells, genes, immunomodulation, neoplasms, antigen presentation, leukemia, genes, p53, therapeutics | 3 Biotech | 2026 | 0 |
LeadR Networks
Main global connection map